If you made any changes in Pure these will be visible here soon.

Personal profile


Associate Professor Curtis is Head of the Division of Blood Cancer Research of the Austraiian Centre for Blood Diseases and member of the Clinical Haematology Service. His research program uses mouse models to dissect the genetic and epigenetic regulation of normal and leukemic stem cells. He is currently an NHMRC Senior Research Fellow B. He has published over 60 papers including articles in Science, Cell Stem Cell, PNAS and Blood.

Associate Professor Curtis completed his training as a Clinical Haematologist and Bone Marrow Transplant Physician through the University of Melbourne in 1994. He was awarded a NHMRC postgraduate scholarship at the Walter and Eliza Hall Institute for Medical Research (1994-1997) which used animal models of hematologic malignancy to study oncogene co-operation. A/Professor Curtis was awarded a NHMRC CJ Martin fellowship for post-doctoral studies in the laboratory of Dr David Bodine at the NIH (1998-2001) to study the function of the non-histone DNA binding HMGB3 protein in adult hematopoietic stem cell. In 2001 A/Professor Curtis returned to Royal Melbourne Hospital to establish a research program focused on the molecular mechanisms that control the fate of normal and malignant hematopoietic stem cells. In 2011, he moved to the Department of Haematology, Monash University and Alfred Health as the head of the new Division of Blood Cancer Research of the Australian Centre for Blood Diseases.

The research program of A/Prof Curtis aims to identify improved therapies for acute leukemia and related blood cancers through the use of mouse models to dissect the genetic and epigenetic mechanisms that control the fate of normal and malignant hematopoietic stem cells. In addition, A/Prof Curtis uses ENU-mutagenesis for discovery of genes that regulate hematopoiesis. Specific areas of focus include the bHLH transcription factor complex that drives T-cell acute lymphoblastic leukemia, the mechanisms of oncogene-induced apoptosis in myelodysplasia, the role of epigenetic changes in acute myeloid leukemia and myelodysplasia and the therapeutic potential of small molecule inhibitors of the protein arginine methyltransferase, PRMT5.

A/Professor Curtis has 60 peer reviewed papers including first or senior author publications in Science (2010), Cell Stem Cell (2009), Nature Structural and Molecular Biology (2009) and Blood (2004, 2006, 2007, 2009, 2011, 2013 and 2015). In 2011, A/Professor Curtis was awarded a Charles and Sylvia Viertel Senior Research Fellowship and honorary NHMRC Practitioner and Victorian Cancer Agency Fellowships. A/Prof Curtis has been on the editorial board for the journal Stem Cells since 2007. A/Prof Curtis has been an invited speaker to conferences including the International Society of Experimental Hematology, New Directions in Leukemia Research and Lorne Cancer Conference. A/Prof Curtis has been an external reviewer for numerous NHMRC project grants since 2005 as well as on the scientific advisory panel for review of Leukemia Foundation and the NSW Cancer Council Program grants. In addition to his research program, he is an active clinical haematologist and bone marrow transplant physician at Alfred Health.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Research area keywords

  • Blood Diseases
  • Epigenetics
  • Leukemia
  • Stem Cell Biology
  • Transplantation biology

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or